Image_2_Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma.eps by Simon Le Gallou (10742601)

“…<p>Absolute count of circulating monocytes has been proposed as an independent prognostic factor in diffuse large B-cell lymphoma (DLBCL). However, monocyte nomenclature includes various subsets with pro-, anti-inflammatory, or suppressive functions, and their clinical relevance in DLBCL has been poorly explored. …”

Image_6_Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma.eps by Simon Le Gallou (10742601)

“…<p>Absolute count of circulating monocytes has been proposed as an independent prognostic factor in diffuse large B-cell lymphoma (DLBCL). However, monocyte nomenclature includes various subsets with pro-, anti-inflammatory, or suppressive functions, and their clinical relevance in DLBCL has been poorly explored. …”

Image_7_Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma.eps by Simon Le Gallou (10742601)

“…<p>Absolute count of circulating monocytes has been proposed as an independent prognostic factor in diffuse large B-cell lymphoma (DLBCL). However, monocyte nomenclature includes various subsets with pro-, anti-inflammatory, or suppressive functions, and their clinical relevance in DLBCL has been poorly explored. …”

S1 Data - by Trevor Crandall (11302250)

Line graph showing the increase or decrease in the average number of bee swarms caught over the past three years (Mean  by Beatrice T. Nganso (4114768)

The polyP pseudo-capsule potentiates the survival of engulfed <i>N</i>. <i>gonorrhoeae</i> by dHL60 and increases bacterial association. by Benedetta Manca (15810991)

Number of associations between two species, i.e., the number of times these two species were observed within the same ’group’ (within 6 body lengths of each other) during one of th... by Claire Gauquelin Des Pallieres (15333248)

Supplementary Material for: Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma by Qing K. (11765465)

“…In OCI-Ly3/DOX cells, NF-κB activity and PRDM1 expression decreased with an increase in drug-resistant index, whereas <i>MDR1</i> expression increased with enhanced drug resistance. …”

Biases in larger populations. by Sander W. Keemink (21253563)

“…Threshold parameter <i>c</i> = − 0 . 1 for the rectified cosine tuning with 4 neurons, and width <i>w</i> was 1 for von Mises tuning. …”

The growth rate <i>μ</i> of the crowding-adjusted whole-cell model constrained at different cytosolic occupancies <i>ρ</i>. by Tin Yau Pang (8756325)

Potential distribution of <i>Atta</i> species. by Jorge A. Gómez-Díaz (17048305)

In superadditive networks, more enhancers decrease noise and fidelity. by Alvaro Fletcher (15675430)

“…Meanwhile <i>d</i>₁, the rate of increase for <i>k</i>_on, was chosen to be 0.01 for both <i>T</i>₁ and <i>T</i>₂ (B) Unlike in the subadditive case, enhancer numbers decrease transcriptional fidelity and also decrease noise. …”

O-GlcNAc immunoprecipitation (IP) for carnitine palmitoyltransferase 1B (CPT1B). by Wei Zhong Zhu (14014073)

Expression, purification, XRCC4 interaction, and <i>in vitro</i> ligation activity of chimeric ligases. by Vidyasagar Malashetty (14676064)

Table1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.docx by Chaofeng Zhang (845343)

“…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). However, the mechanisms by which CISD2 regulates the occurrence and development of DLBCL remain to be fully elucidated.…”

Image_1_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg by Qikai Zhang (6905096)

“…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …”

Image1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.JPEG by Chaofeng Zhang (845343)

“…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). However, the mechanisms by which CISD2 regulates the occurrence and development of DLBCL remain to be fully elucidated.…”

Image_1_The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.jpeg by Zhouning Lin (14648597)

“…Background<p>Gut microbiota characteristics in patients with diffuse large B-cell lymphoma (DLBCL) are reportedly different when compared with the healthy population and it remains unclear if the gut microbiota affects host immunity and clinical disease features. …”

Fluorescence analysis of wild-type and p.R163C αB-crystallin proteins. by Aref Baharvand (21713886)

Subjects:

K2 increases the sensitivity of <i>K</i>. <i>pneumoniae</i> to polymyxin B. by Estelle Ifrid (10076719)

Subjects: